Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Buy | Transaction Date : 21/06/2018

Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 22/06/2018

Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 25/06/2018

Of Details DOD BIOTECH PUBLIC COMPANY LIMITED 2021   Company Year 31/12/2021 DOD BIOTECH PUBLIC COMPANY LIMITED 2021   Consolidated Year 31/12/2021 DOD BIOTECH PUBLIC COMPANY LIMITED 2021 Reviewed

presentation of the investment amount and the gains from loss of control in subsidiaries. In addition, the information disclosed in its Q2 and Q3/2017 financial statements were incomplete and ambiguous, which is

in its Q2 and Q3/2017 financial statements were incomplete and ambiguous, which is likely to affect the rights and interests of shareholders or the decision making on investment. For example, an

invest in some claim-to-be digital tokens which is in fact another form of Ponzi scheme. Such scheme can be detected by ambiguous business plans, products or platforms, as well as the lack of trustworthy

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 No. DOD089/2563

accounting and approval of the disposal of investmentsBS Myco Biotech Company Limited ( 2 st review) 28/12/2021 19:33 Notification of the resignation of the Company's director and appointment of a supervisor